Angiogenesis in Interstitial Lung Diseases: a pathogenetic hallmark or a bystander?

by Anevlavis Stavros, Tzouvelekis Argyris, Bouros Demosthenes
Published 2006-05-01

Serum biomarkers in interstitial lung diseases

by Anevlavis Stavros, Kouliatsis George, Tzouvelekis Argyris, Bouros Demosthenes
Published 2005-07-01

Use of interrupter technique in assessment of bronchial responsiveness in normal subjects

by Anevlavis Stavros, Tzouvelekis Argyris, Kottakis Ioannis, Panagou Panagiotis, Bouros Demosthenes
Published 2004-11-01

The clinical significance of serum and bronchoalveolar lavage inflammatory cytokines in patients at risk for Acute Respiratory Distress Syndrome

by Patlakas George, Pataka Athanasia, Anevlavis Stavros, Pneumatikos Ioannis, Agouridakis Panagiotis, Antoniou Katerina M, Alexandrakis Michael G, Bouros Demosthenes, Karkavitsas Nikolaos, Kyriakou Despina
Published 2004-08-01

Expression of Hypoxia-Inducible Factor (HIF)-1a-Vascular Endothelial Growth Factor (VEGF)-Inhibitory Growth Factor (ING)-4- axis in sarcoidosis patients

by Tzouvelekis Argyris, Ntolios Paschalis, Karameris Andreas, Koutsopoulos Anastasios, Boglou Panagiotis, Koulelidis Andreas, Archontogeorgis Kostas, Zacharis George, Drakopanagiotakis Fotis, Steiropoulos Paschalis, Anevlavis Stavros, Polychronopoulos Vlassis, Mikroulis Dimitrios, Bouros Demosthenes
Published 2012-11-01